Complement activation in patients with COVID-19: A novel therapeutic target

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 146; no. 1; pp. 215 - 217
Main Authors Cugno, Massimo, Meroni, Pier Luigi, Gualtierotti, Roberta, Griffini, Samantha, Grovetti, Elena, Torri, Adriana, Panigada, Mauro, Aliberti, Stefano, Blasi, Francesco, Tedesco, Francesco, Peyvandi, Flora
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2020
American Academy of Allergy, Asthma & Immunology
Subjects
Adult
Aged
Aged, 80 and over
Betacoronavirus
Complement Activation - physiology
Complement C5a - analysis
Complement Membrane Attack Complex - analysis
Coronavirus Infections - blood
Coronavirus Infections - immunology
COVID-19
Female
Humans
Letter to the Editor
Male
Middle Aged
Pandemics
Pneumonia, Viral - blood
Pneumonia, Viral - immunology
SARS-CoV-2
Online AccessGet full text
ISSN0091-6749
1097-6825
1097-6825
DOI10.1016/j.jaci.2020.05.006

Cover

Author Cugno, Massimo
Gualtierotti, Roberta
Griffini, Samantha
Meroni, Pier Luigi
Panigada, Mauro
Blasi, Francesco
Peyvandi, Flora
Torri, Adriana
Grovetti, Elena
Aliberti, Stefano
Tedesco, Francesco
Author_xml – sequence: 1
  givenname: Massimo
  surname: Cugno
  fullname: Cugno, Massimo
  email: massimo.cugno@unimi.it
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
– sequence: 2
  givenname: Pier Luigi
  surname: Meroni
  fullname: Meroni, Pier Luigi
  organization: Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy
– sequence: 3
  givenname: Roberta
  surname: Gualtierotti
  fullname: Gualtierotti, Roberta
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
– sequence: 4
  givenname: Samantha
  surname: Griffini
  fullname: Griffini, Samantha
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
– sequence: 5
  givenname: Elena
  surname: Grovetti
  fullname: Grovetti, Elena
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
– sequence: 6
  givenname: Adriana
  surname: Torri
  fullname: Torri, Adriana
  organization: Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
– sequence: 7
  givenname: Mauro
  surname: Panigada
  fullname: Panigada, Mauro
  organization: Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, UOC Anestesia e Terapia Intensiva Adulti, Milan, Italy
– sequence: 8
  givenname: Stefano
  surname: Aliberti
  fullname: Aliberti, Stefano
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
– sequence: 9
  givenname: Francesco
  surname: Blasi
  fullname: Blasi, Francesco
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
– sequence: 10
  givenname: Francesco
  surname: Tedesco
  fullname: Tedesco, Francesco
  organization: Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy
– sequence: 11
  givenname: Flora
  surname: Peyvandi
  fullname: Peyvandi, Flora
  organization: Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32417135$$D View this record in MEDLINE/PubMed
BookMark eNqFkcFu1DAQhi1URLeFF-CAcuSSMHYcJ6kQUrVQqLRSL8DV8k4mXS9JvNjeRX0bnoUnw9ttEfRQTrZn5vt_a_4TdjS5iRh7yaHgwNWbdbE2aAsBAgqoCgD1hM04tHWuGlEdsRlAy3NVy_aYnYSwhvQum_YZOy6F5DUvqxlbzN24GWikKWYGo92ZaN2U2SnbpFuqhuyHjatsfvX18n3O27Ps_NfPye1oyOKKvNnQNlrMovHXFJ-zp70ZAr24O0_Zl4sPn-ef8sXVx8v5-SLHClTMEYVcSqoQahSCS4ES2mUvDDTYSAIwXdV0pexFU5egFCKkJnZN33PVtlCesncH3c12OVKH6ZveDHrj7Wj8jXbG6n87k13pa7fTtRBS1U0SeH0n4N33LYWoRxuQhsFM5LZBCwmyrFVZ771e_e31x-R-hWmgOQygdyF46jXaeLvFZG0HzUHv09JrvU9L79PSUOmUVkLFA_Re_VHo7QGitOGdJa8DpqCQOusJo-6cfRw_e4DjYCeLZvhGN_-DfwMTGMIX
CitedBy_id crossref_primary_10_1097_MBC_0000000000000993
crossref_primary_10_1016_j_ajo_2021_05_024
crossref_primary_10_2147_VHRM_S299357
crossref_primary_10_1007_s10096_020_04138_6
crossref_primary_10_1093_oxfimm_iqaa005
crossref_primary_10_1016_j_heliyon_2023_e17148
crossref_primary_10_1002_jcla_23618
crossref_primary_10_52727_2078_256X_2021_3_97_105
crossref_primary_10_1007_s40121_023_00759_4
crossref_primary_10_1016_j_it_2020_12_002
crossref_primary_10_3389_fimmu_2020_01606
crossref_primary_10_1007_s12195_021_00685_w
crossref_primary_10_1080_08830185_2020_1800688
crossref_primary_10_1016_j_jaut_2024_103299
crossref_primary_10_1016_j_smim_2022_101640
crossref_primary_10_3389_fimmu_2022_1056153
crossref_primary_10_1007_s12291_022_01033_z
crossref_primary_10_1016_j_smim_2022_101644
crossref_primary_10_3390_biom12020226
crossref_primary_10_1097_APO_0000000000000346
crossref_primary_10_4081_btvb_2022_48
crossref_primary_10_3389_fimmu_2020_584241
crossref_primary_10_3389_fimmu_2021_671052
crossref_primary_10_1016_j_autrev_2022_103232
crossref_primary_10_1016_j_celrep_2021_109798
crossref_primary_10_1055_s_0043_1776713
crossref_primary_10_1016_j_jaut_2021_102595
crossref_primary_10_3389_fimmu_2020_594849
crossref_primary_10_3389_fimmu_2021_680567
crossref_primary_10_1016_j_imbio_2020_152008
crossref_primary_10_1016_j_blre_2022_100995
crossref_primary_10_1172_JCI141374
crossref_primary_10_3389_fimmu_2024_1440314
crossref_primary_10_1016_j_clim_2020_108555
crossref_primary_10_1371_journal_pone_0264106
crossref_primary_10_1038_s41467_021_23036_9
crossref_primary_10_1186_s12933_023_02097_8
crossref_primary_10_1016_j_clim_2021_108716
crossref_primary_10_1055_s_0040_1716735
crossref_primary_10_15690_vramn1474
crossref_primary_10_1159_000517659
crossref_primary_10_3390_ijerph191811437
crossref_primary_10_1016_j_heliyon_2023_e17370
crossref_primary_10_1080_08830185_2020_1840567
crossref_primary_10_1515_hsz_2021_0245
crossref_primary_10_3389_fimmu_2021_767981
crossref_primary_10_1038_s41467_020_18854_2
crossref_primary_10_1126_sciadv_abo2341
crossref_primary_10_3390_v13122376
crossref_primary_10_1016_j_thromres_2022_09_025
crossref_primary_10_3389_fimmu_2021_791429
crossref_primary_10_3390_hematolrep14040050
crossref_primary_10_3389_fimmu_2020_02072
crossref_primary_10_3390_biomedicines11051371
crossref_primary_10_1080_08830185_2021_1883600
crossref_primary_10_1007_s00430_021_00704_7
crossref_primary_10_4103_sjhs_sjhs_168_20
crossref_primary_10_1038_s41591_021_01283_z
crossref_primary_10_1038_s41577_021_00665_1
crossref_primary_10_1038_s41569_021_00665_7
crossref_primary_10_23736_S0031_0808_20_03999_3
crossref_primary_10_3390_ijms232214340
crossref_primary_10_1007_s12026_022_09265_0
crossref_primary_10_3390_ijms25137209
crossref_primary_10_3324_haematol_2020_262345
crossref_primary_10_1016_j_antiviral_2024_105968
crossref_primary_10_1016_j_cyto_2021_155628
crossref_primary_10_15789_1563_0625_POA_2465
crossref_primary_10_1038_s41581_021_00452_0
crossref_primary_10_3390_v13122513
crossref_primary_10_1097_IMNA_D_22_00022
crossref_primary_10_3389_fcvm_2021_785738
crossref_primary_10_1097_SHK_0000000000001956
crossref_primary_10_1001_jamanetworkopen_2023_1713
crossref_primary_10_4081_mrm_2021_741
crossref_primary_10_3389_fcell_2022_824851
crossref_primary_10_1124_pharmrev_120_000072
crossref_primary_10_1007_s00430_020_00696_w
crossref_primary_10_1016_j_clim_2020_108598
crossref_primary_10_1016_j_intimp_2021_107516
crossref_primary_10_3389_fimmu_2021_664209
crossref_primary_10_1038_s41598_022_12252_y
crossref_primary_10_1126_sciimmunol_abh2259
crossref_primary_10_3389_fimmu_2022_953129
crossref_primary_10_1007_s00430_021_00725_2
crossref_primary_10_1111_jth_15191
crossref_primary_10_1007_s11239_021_02468_6
crossref_primary_10_1096_fj_202201340RR
crossref_primary_10_1126_sciimmunol_abg0833
crossref_primary_10_1053_j_ajkd_2022_07_012
crossref_primary_10_1016_j_ccc_2021_05_004
crossref_primary_10_1073_pnas_2010540117
crossref_primary_10_1016_j_humimm_2021_01_007
crossref_primary_10_1097_CRD_0000000000000422
crossref_primary_10_2217_fvl_2021_0048
crossref_primary_10_1080_21505594_2021_1898790
crossref_primary_10_3390_microorganisms10061191
crossref_primary_10_3390_pharmaceutics14091906
crossref_primary_10_3324_haematol_2021_279155
crossref_primary_10_1016_j_ijcard_2020_11_016
crossref_primary_10_17816_rmmar76904
crossref_primary_10_5507_bp_2020_037
crossref_primary_10_1093_qjmed_hcad159
crossref_primary_10_3390_ijms23158606
crossref_primary_10_1097_MBC_0000000000001212
crossref_primary_10_24911_IJMDC_51_1615149138
crossref_primary_10_1016_j_tim_2022_12_008
crossref_primary_10_1111_jth_15050
crossref_primary_10_1016_j_eclinm_2020_100590
crossref_primary_10_1111_nep_14225
crossref_primary_10_3389_fimmu_2021_780804
crossref_primary_10_1016_j_beha_2022_101376
crossref_primary_10_26508_lsa_202001009
crossref_primary_10_1016_j_compbiolchem_2021_107482
crossref_primary_10_1016_j_molimm_2022_11_010
crossref_primary_10_1016_j_phymed_2022_154551
crossref_primary_10_3390_genes11121447
crossref_primary_10_1016_j_clim_2022_109016
crossref_primary_10_3390_polym14153130
crossref_primary_10_1097_CCE_0000000000000374
crossref_primary_10_1080_13543784_2024_2315128
crossref_primary_10_1159_000512932
crossref_primary_10_1007_s10067_020_05275_1
crossref_primary_10_3389_fimmu_2024_1337215
crossref_primary_10_3389_fimmu_2022_941742
crossref_primary_10_1007_s10875_021_01061_z
crossref_primary_10_3390_ijms231911338
crossref_primary_10_1016_j_berh_2021_101661
crossref_primary_10_3389_fimmu_2022_953043
crossref_primary_10_1186_s12929_021_00784_w
crossref_primary_10_3389_fimmu_2021_668725
crossref_primary_10_4049_jimmunol_2100606
crossref_primary_10_1128_spectrum_01671_21
crossref_primary_10_1007_s10238_021_00769_x
crossref_primary_10_1088_1758_5090_ad4c0b
crossref_primary_10_5468_ogs_22175
crossref_primary_10_3389_fimmu_2020_01661
crossref_primary_10_1080_1744666X_2021_1905526
crossref_primary_10_1172_jci_insight_140711
crossref_primary_10_1186_s12931_020_01516_8
crossref_primary_10_1002_rmv_2316
crossref_primary_10_1007_s10557_021_07207_w
crossref_primary_10_1080_07391102_2020_1820381
crossref_primary_10_3389_fimmu_2021_707159
crossref_primary_10_1038_s41586_020_2600_6
crossref_primary_10_1172_JCI163105
crossref_primary_10_1038_s41392_022_00907_1
crossref_primary_10_1093_ckj_sfaa192
crossref_primary_10_1111_joim_13783
crossref_primary_10_1080_23744235_2021_1971289
crossref_primary_10_3390_ijms25073704
crossref_primary_10_1016_j_biopha_2021_111234
crossref_primary_10_1007_s12275_022_2037_8
crossref_primary_10_1055_s_0041_1740182
crossref_primary_10_1186_s13104_020_05241_9
crossref_primary_10_3389_fimmu_2022_946522
crossref_primary_10_1016_S2213_2600_21_00218_6
crossref_primary_10_3389_fimmu_2022_840137
crossref_primary_10_1016_j_jaip_2020_11_042
crossref_primary_10_1159_000512503
crossref_primary_10_3389_fimmu_2022_835104
crossref_primary_10_1038_s41392_020_00454_7
crossref_primary_10_1016_S2665_9913_20_30353_2
crossref_primary_10_1038_s41577_021_00634_8
crossref_primary_10_1016_j_jaut_2020_102560
crossref_primary_10_1038_s41418_021_00805_z
crossref_primary_10_3390_microorganisms9030467
crossref_primary_10_3390_cimb45070361
crossref_primary_10_1007_s12325_021_01704_y
crossref_primary_10_1038_s41392_021_00731_z
crossref_primary_10_1080_22221751_2025_2467781
crossref_primary_10_1038_s41598_022_09343_1
crossref_primary_10_3389_fimmu_2021_627579
crossref_primary_10_1182_blood_2020008248
crossref_primary_10_3389_fimmu_2020_599417
crossref_primary_10_2491_jjsth_32_625
crossref_primary_10_1093_infdis_jiad462
crossref_primary_10_3390_biomedicines9081003
crossref_primary_10_1016_S2665_9913_20_30341_6
crossref_primary_10_1515_cclm_2024_0800
crossref_primary_10_1161_ATVBAHA_120_314513
crossref_primary_10_1016_j_intimp_2022_109040
crossref_primary_10_1136_annrheumdis_2020_219724
crossref_primary_10_3389_fimmu_2024_1419165
crossref_primary_10_3389_fimmu_2021_605212
crossref_primary_10_1093_infdis_jiaa646
crossref_primary_10_1136_jim_2021_002224
crossref_primary_10_1016_j_addr_2021_113848
crossref_primary_10_1002_eji_202048858
crossref_primary_10_3390_ijms22147582
crossref_primary_10_1021_acsbiomaterials_0c01287
crossref_primary_10_1038_s41577_021_00656_2
crossref_primary_10_1016_j_imbio_2023_152393
crossref_primary_10_1055_a_1760_0445
crossref_primary_10_1055_s_0040_1715835
Cites_doi 10.1172/JCI117520
10.1128/mBio.01753-18
10.1101/2020.03.04.20031120
10.1101/2020.03.29.20041962
10.1016/S0140-6736(20)30937-5
10.1016/j.tmrv.2019.09.004
10.1055/s-0034-1376153
10.1172/JCI137244
10.1056/NEJMoa2002032
ContentType Journal Article
Copyright 2020 American Academy of Allergy, Asthma & Immunology
2020 American Academy of Allergy, Asthma & Immunology. 2020 American Academy of Allergy, Asthma & Immunology
Copyright_xml – notice: 2020 American Academy of Allergy, Asthma & Immunology
– notice: 2020 American Academy of Allergy, Asthma & Immunology. 2020 American Academy of Allergy, Asthma & Immunology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.jaci.2020.05.006
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 217
ExternalDocumentID PMC7224678
32417135
10_1016_j_jaci_2020_05_006
S0091674920306503
Genre Letter
Correspondence
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
EFLBG
5PM
ID FETCH-LOGICAL-c506t-cc24b4e5c07c22142c409bf2a08c84e00ad58d34f2873066cc0f2acd8ff169903
IEDL.DBID AIKHN
ISSN 0091-6749
1097-6825
IngestDate Thu Aug 21 18:09:45 EDT 2025
Fri Sep 05 14:30:55 EDT 2025
Thu Apr 03 07:04:43 EDT 2025
Tue Jul 01 04:21:45 EDT 2025
Thu Apr 24 22:52:26 EDT 2025
Sun Apr 06 06:53:25 EDT 2025
Tue Aug 26 17:44:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c506t-cc24b4e5c07c22142c409bf2a08c84e00ad58d34f2873066cc0f2acd8ff169903
Notes content type line 23
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7224678
PMID 32417135
PQID 2404376370
PQPubID 23479
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7224678
proquest_miscellaneous_2404376370
pubmed_primary_32417135
crossref_citationtrail_10_1016_j_jaci_2020_05_006
crossref_primary_10_1016_j_jaci_2020_05_006
elsevier_sciencedirect_doi_10_1016_j_jaci_2020_05_006
elsevier_clinicalkey_doi_10_1016_j_jaci_2020_05_006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-01
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2020
Publisher Elsevier Inc
American Academy of Allergy, Asthma & Immunology
Publisher_xml – name: Elsevier Inc
– name: American Academy of Allergy, Asthma & Immunology
References Gao T, Hu M, Zhang X, Li H, Zhu L, Liu H, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation [published online ahead of print April 7, 2020]. medRxiv.
Riedl, Fakhouri, Le Quintrec, Noone, Jungraithmayr, Fremeaux-Bacchi (bib3) 2014; 40
Basta, Dalakas (bib9) 1994; 94
Varga, Flammer, Steiger, Haberecker, Andermatt, Zinkernagel (bib7) 2020; 395
Patriquin, Kuo (bib8) 2019; 33
Chen, Wu, Guo, Cao, Huang, Wang (bib2) 2020; 130
Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [published online ahead of print April 10, 2020]. medRxiv.
.
Guan, Ni, Hu, Liang, Ou, He (bib1) 2020; 382
Gralinski, Sheahan, Morrison, Menachery, Jensen, Leist (bib4) 2018; 9
10.1016/j.jaci.2020.05.006_bib6
Gralinski (10.1016/j.jaci.2020.05.006_bib4) 2018; 9
Guan (10.1016/j.jaci.2020.05.006_bib1) 2020; 382
10.1016/j.jaci.2020.05.006_bib5
Varga (10.1016/j.jaci.2020.05.006_bib7) 2020; 395
Patriquin (10.1016/j.jaci.2020.05.006_bib8) 2019; 33
Riedl (10.1016/j.jaci.2020.05.006_bib3) 2014; 40
Basta (10.1016/j.jaci.2020.05.006_bib9) 1994; 94
Chen (10.1016/j.jaci.2020.05.006_bib2) 2020; 130
References_xml – reference: Gao T, Hu M, Zhang X, Li H, Zhu L, Liu H, et al. Highly pathogenic coronavirus N protein aggravates lung injury by MASP-2-mediated complement over-activation [published online ahead of print April 7, 2020]. medRxiv.
– volume: 33
  start-page: 256
  year: 2019
  end-page: 265
  ident: bib8
  article-title: Eculizumab and beyond: the past, present, and future of complement therapeutics
  publication-title: Transfusion Med Rev
– volume: 40
  start-page: 444
  year: 2014
  end-page: 464
  ident: bib3
  article-title: Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches
  publication-title: Semin Thromb Hemost
– volume: 382
  start-page: 1708
  year: 2020
  end-page: 1720
  ident: bib1
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N Engl J Med
– volume: 130
  start-page: 2620
  year: 2020
  end-page: 2629
  ident: bib2
  article-title: Clinical and immunologic features in severe and moderate Coronavirus Disease 2019
  publication-title: J Clin Invest
– volume: 9
  year: 2018
  ident: bib4
  article-title: Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis
  publication-title: mBio
– volume: 94
  start-page: 1729
  year: 1994
  end-page: 1735
  ident: bib9
  article-title: High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
  publication-title: J Clin Invest
– volume: 395
  start-page: 1417
  year: 2020
  end-page: 1418
  ident: bib7
  article-title: Endothelial cell infection and endotheliitis in COVID-19
  publication-title: Lancet
– reference: Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection [published online ahead of print April 10, 2020]. medRxiv.
– reference: .
– volume: 94
  start-page: 1729
  year: 1994
  ident: 10.1016/j.jaci.2020.05.006_bib9
  article-title: High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments
  publication-title: J Clin Invest
  doi: 10.1172/JCI117520
– volume: 9
  year: 2018
  ident: 10.1016/j.jaci.2020.05.006_bib4
  article-title: Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis
  publication-title: mBio
  doi: 10.1128/mBio.01753-18
– ident: 10.1016/j.jaci.2020.05.006_bib5
  doi: 10.1101/2020.03.04.20031120
– ident: 10.1016/j.jaci.2020.05.006_bib6
  doi: 10.1101/2020.03.29.20041962
– volume: 395
  start-page: 1417
  year: 2020
  ident: 10.1016/j.jaci.2020.05.006_bib7
  article-title: Endothelial cell infection and endotheliitis in COVID-19
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30937-5
– volume: 33
  start-page: 256
  year: 2019
  ident: 10.1016/j.jaci.2020.05.006_bib8
  article-title: Eculizumab and beyond: the past, present, and future of complement therapeutics
  publication-title: Transfusion Med Rev
  doi: 10.1016/j.tmrv.2019.09.004
– volume: 40
  start-page: 444
  year: 2014
  ident: 10.1016/j.jaci.2020.05.006_bib3
  article-title: Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches
  publication-title: Semin Thromb Hemost
  doi: 10.1055/s-0034-1376153
– volume: 130
  start-page: 2620
  year: 2020
  ident: 10.1016/j.jaci.2020.05.006_bib2
  article-title: Clinical and immunologic features in severe and moderate Coronavirus Disease 2019
  publication-title: J Clin Invest
  doi: 10.1172/JCI137244
– volume: 382
  start-page: 1708
  year: 2020
  ident: 10.1016/j.jaci.2020.05.006_bib1
  article-title: Clinical characteristics of coronavirus disease 2019 in China
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2002032
SSID ssj0009389
Score 2.6625214
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 215
SubjectTerms Adult
Aged
Aged, 80 and over
Betacoronavirus
Complement Activation - physiology
Complement C5a - analysis
Complement Membrane Attack Complex - analysis
Coronavirus Infections - blood
Coronavirus Infections - immunology
COVID-19
Female
Humans
Letter to the Editor
Male
Middle Aged
Pandemics
Pneumonia, Viral - blood
Pneumonia, Viral - immunology
SARS-CoV-2
Title Complement activation in patients with COVID-19: A novel therapeutic target
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674920306503
https://dx.doi.org/10.1016/j.jaci.2020.05.006
https://www.ncbi.nlm.nih.gov/pubmed/32417135
https://www.proquest.com/docview/2404376370
https://pubmed.ncbi.nlm.nih.gov/PMC7224678
Volume 146
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VrYS4IP5ZoJWRuKFQ24kTm9tqS7UFWi4U9WY5jiNSVdmKbjnyLDwLT8bM2lm6LSoSx8QeyRrb4xn7m28AXlWtwbAiYHSCzkZW1EZlrjUik85r4V0jckcvugeH5eyoeH-sjjdgOuTCEKwy2f5o05fWOv3ZSdrcOes6yvE1BKE3ktxeRYyfmzI3pRrB5mT_w-zwD_durqMXjGMggZQ7E2FeJ853GCZKviTwpMJHfz-frvufV2GUl86lvXtwNzmUbBLHfB82Qv8Abh-kJ_OH8JF2fMSIM0piiFewrOtZolQ9Z3QXy6afvuzvZsK8ZZNfP_v593DKLuVmsYgYfwRHe-8-T2dZKqGQecXLRea9LOoiKM8rL4ldzWM8V7fSce11ETh3jdJNXrQYOKEWS-85NvpGt60o8aDKH8Oon_fhKbC21k3ltapNURZ1oJReVQWhavQhjJNuDGJQnPWJX5zKXJzaAUh2YknZlpRtubKo7DG8XsmcRXaNG3vnw3zYIW8ULZ1F43-jlFpJra2sf8q9HKbc4pajdxTXh_nFuZXESIR2ueJjeBKXwGr06J8Kqno4hmptcaw6EJ33ekvffV3SelfE7VfpZ_853udwh74ilPgFjBbfLsIWOkyLehtuvfkhttO2-A3QaRRC
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB5VRQIuiH-WXyNxQ6FOYsc2t2qh2sJuubSoN8txHDVVla3otsc-C8_CkzGzdpYuoCJxjT3SaGKPZ-xvvgF4o1qDaUXA7ASDjUzURmauNXlWOK9z75q8dPSiO9urJgfi06E83IDxUAtDsMrk-6NPX3rr9GUrWXPrtOuoxtcQhN4UFPZKYvy8IWSpCNf37vIXzsOUOsbAqAFNT5UzEeR17HyHSWLBl_Sd1Pbo76fTn9Hn7yDKK6fSzl24k8JJth01vgcbob8PN2fpwfwBTGm_R4Q4oxKGeAHLup4lQtUzRjexbPzl6-6HLDfv2faP7_38IpywK5VZLOLFH8LBzsf98SRLDRQyL3m1yLwvRC2C9Fz5grjVPGZzdVs4rr0WgXPXSN2UosW0CW1Yec9x0De6bfMKj6nyEWz28z48AdbWulFey9qIStSBCnqlCrmsMYIwrnAjyAfDWZ_YxanJxYkdYGTHloxtydiWS4vGHsHblcxp5Na4dnY5_A87VI2in7Po-q-VkiuptXX1T7nXwy-3uOHoFcX1YX5-ZgviI0KvrPgIHsclsNIeo9Oceh6OQK0tjtUEIvNeH-m7oyWptyJmP6Wf_qe-r-DWZH82tdPdvc_P4DaNRFDxc9hcfDsPLzB0WtQvl1vjJyoUFQ0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Complement+activation+in+patients+with+COVID-19%3A+A%C2%A0novel+therapeutic+target&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Cugno%2C+Massimo&rft.au=Meroni%2C+Pier+Luigi&rft.au=Gualtierotti%2C+Roberta&rft.au=Griffini%2C+Samantha&rft.date=2020-07-01&rft.pub=Elsevier+Inc&rft.issn=0091-6749&rft.volume=146&rft.issue=1&rft.spage=215&rft.epage=217&rft_id=info:doi/10.1016%2Fj.jaci.2020.05.006&rft.externalDocID=S0091674920306503
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-6749&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-6749&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-6749&client=summon